Portfolio Lab

L`Oreal

  • Stock
  • Ticker LRLCY
  • ISIN US5021172037
  • OTC

France

$94.48 −1.31%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of L`Oreal since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

LRLCYGlobal equities (VT)

$10,000 grew to $33,249. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −39.0% in 11/2022, measured from the peak in 11/2021. It took 17 months to get back to the old peak.

1-year return
+19.8%
5-year return p.a.
+1.3%
10-year return p.a.
+12.8%
Volatility p.a.
22.0%
Largest decline
−39.0%

Financial statements

Amounts in € millions from the company's annual financial reports, earnings per share in € per ordinary share

Fiscal year202020212022202320242025
Income statement
Revenue27,99232,28838,26141,18343,48744,052
Gross profit20,46023,85427,68330,41632,26032,739
Operating income4,5005,7287,2157,6938,2508,387
Net income3,5684,6025,7136,1916,4176,134
Earnings per share6.348.2110.6111.5211.9511.44
Balance sheet
Total assets43,60743,01346,84451,85556,35361,821
Liabilities14,60819,42119,65822,77423,21626,817
Equity28,99923,59327,18729,08233,13835,004
Cash6,4062,7142,6184,2884,0529,865
Long-term debt8.5113,0184,7475,1878,070
Cash flow
Operating cash flow6,4536,7286,2787,6058,2868,657
Capital expenditure-972-1,075-1,343–––
Free cash flow5,4815,6534,935–––

Annual returns

Best year 2023 at +41.4%, weakest 2024 at −28.1%. 7 of 9 full years were positive. * partial year.

Key metrics

Key figures as of 21 Nov 2026 from the company's latest annual financial report, amounts converted to US dollars at the ECB reference rate. Valuation and market cap appear only where price and earnings per share reliably refer to the same share.

Valuation

Market cap
€226bn
Market cap in trading currency
$249bn
Enterprise value
$249bn
P/E
37.1
P/S
5.15
P/B
6.49
EV/Sales
5.15
EV/EBITDA
–
Earnings yield
2.7%
FCF yield
–

Results (latest fiscal year)

Revenue
$48.4bn
Gross profit
$36.0bn
EBITDA
–
Net income
$6.73bn
Earnings per share
$12.57
Revenue growth
+1.3%
Earnings growth
−4.4%

Profitability

Gross margin
74.3%
Operating margin
19.0%
Net margin
13.9%
Return on equity
18.0%
Return on assets
9.9%

Balance sheet and cash flow

Cash
$10.8bn
Financial debt
$11.1bn
Debt/equity %
29
Current ratio
1.44
Book value per share
$71.97
Operating cash flow
$9.51bn
Free cash flow
–

Dividend

Dividend yield
1.74%
Dividend (12 months)
$1.64
Yield (12 months)
1.74%
Payout ratio
64%
Ex-dividend date
28 Apr 2026

Shares and trading

Shares outstanding
534m
Volume
183,237
Avg. volume 3 months
177,592
Relative volume
1.0

Price and technicals

Price
$94.48
1 day
−1.3%
52-week high
$101.72
52-week low
$79.24
Distance to 52-week high
−7.1%
Distance to 52-week low
+19.2%
Distance to 50-day line
+2.9%
Distance to 200-day line
+7.3%
RSI (14)
45
Volatility 1M
21.9%

Performance

1 week
−4.9%
1 month
−3.0%
3 months
+3.3%
6 months
+12.8%
YTD
+10.3%
1 year
+16.8%

Dates

Fiscal year end
31 Dec 2025

Frequently asked questions

How has LRLCY performed since 11/2016?

$10,000 grew to $33,249 by 20 Nov 2026, which is +12.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is LRLCY?

Volatility was 22.0% per year, measured on monthly returns. The largest decline from a peak was −39.0%, with the low in 11/2022.

How does LRLCY compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, LRLCY returned +12.8% at 22.0%. The correlation of monthly returns was 0.58; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Key figures and financial statements calculated from the company's annual financial reports, without guarantee; key figures converted to US dollars at the ECB reference rate, statements in the currency of the report.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

L`Oreal (LRLCY): Return and risk | Portfolio Lab